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Abstract
Infertility and adverse gynecological outcomes such as preeclampsia and miscarriage represent significant female
reproductive health concerns. The spatiotemporal expression of growth factors indicates that they play an important role in
pregnancy. The goal of this study is to define the role of the ERBB family of growth factor receptors in endometrial function.
Using conditional ablation in mice and siRNA in primary human endometrial stromal cells, we identified the epidermal
growth factor receptor (Egfr) to be critical for endometrial function during early pregnancy. While ablation of Her2 or Erbb3
led to only a modest reduction in litter size, mice lacking Egfr expression are severely subfertile. Pregnancy demise occurred
shortly after blastocyst implantation due to defects in decidualization including decreased proliferation, cell survival,
differentiation and target gene expression. To place Egfr in a genetic regulatory hierarchy, transcriptome analyses was used
to compare the gene signatures from mice with conditional ablation of Egfr, wingless-related MMTV integration site 4
(Wnt4) or boneless morphogenic protein 2 (Bmp2); revealing that not only are Bmp2 and Wnt4 key downstream effectors of
Egfr, but they also regulate distinct physiological functions. In primary human endometrial stromal cells, marker gene
expression, a novel high content image-based approach and phosphokinase array analysis were used to demonstrate that
EGFR is a critical regulator of human decidualization. Furthermore, inhibition of EGFR signaling intermediaries WNK1 and
AKT1S1, members identified in the kinase array and previously unreported to play a role in the endometrium, also attenuate
decidualization. These results demonstrate that EGFR plays an integral role in establishing the cellular context necessary for
successful pregnancy via the activation of intricate signaling and transcriptional networks, thereby providing valuable
insight into potential therapeutic targets.
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Introduction
Human reproduction is remarkably inefficient with a mere 30%
of human chorionic gonadotropin (hCG) positive pregnancies result-
ing in live birth [1–3]. Furthermore, an estimated 9% of couples are
considered infertile [4]. Pregnancy is a complex, sequential series of
events including fertilization, blastocyst attachment and implanta-
tion, uterine decidualization, placentation, and parturition (reviewed
in [5]). Defects or a failure in any one process results in a ripple effect
of detrimental consequences and potentially pregnancy demise [6].
Detailed studies assessing at which stage of pregnancy failures occur
indicate that approximately 30% are lost preimplantation, primarily
due to genetic defects in the embryo [7–9]. Another 30% of preg-
nancies are lost in the immediate few weeks following implantation
[7], and there is a remaining 9–12% risk for women under 35 years
of age to miscarry between 6–12 weeks [1]. Moreover, 1–2% of
couples, nearly one-third of which experience clinical depression,
suffer from 3 or more consecutive pregnancy losses [10]. When
women with recurrent pregnancy loss finally do maintain a
pregnancy, they are at increased risk for many adverse obstetric
outcomes including preterm birth, placenta previa and low birth
weight [11]. While some phenomena like embryonic chromosomal
abnormalities have been identified, 50–75% of couples with
recurrent pregnancy loss show no identified causes [12].
Furthering the understanding of the mechanisms regulating
early pregnancy is of paramount importance. The preeminent
factors governing female reproductive health are the steroid hor-
mones progesterone and estrogen. While estrogen is known for its
mitogenic effects and temporal influence on the window of recep-
tivity [13], progesterone is the predominant hormone of pregnancy
(reviewed in [14]). The use of transgenic and knockout animals
has done much to advance our understanding of the molecular
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mediators of pregnancy, including those regulated by progesterone.
Particularly compelling was the identification of a signaling axis in
which the progesterone receptor (Pgr)-mediated induction of indian
hedgehog (Ihh) leads to the stromal induction of the chicken oval-
bumin upstream promoter-transcription factor (Nr2f2; COUP-
TFII), as mice lacking any of these genes are infertile [15–17].
Interestingly, previous works indicate that epidermal growth factor
(EGF) signaling is downstream of this signaling axis [16,18].
The spatiotemporal expression of EGF family members during
the implantation period has led to the longstanding interest in the
role of growth factor signaling in reproduction [19–21]. Of parti-
cular interest is the heparin-binding epidermal growth factor-like
growth factor (HB-EGF, Hegf1), due to its expression in the luminal
epithelium surrounding blastocysts at the time of attachment and
the effects it has on blastocysts [22,23]. Furthermore, blastocysts
express HB-EGF, and it has been shown to influence uterine
decidualization [24]. However, maternal ablation of HB-EGF
expression did not render mice infertile, rather these females
exhibited a deferred implantation window and reduced litter size.
The lack of complete infertility led to the speculation that this
phenotype was due to compensation by elevated expression of the
ligand amphiregulin (Areg) [25]. These results, coupled with the fact
that triple knockout females lacking expression of Areg, Egf and Tgfa
[26] are fertile, together suggest that the ligands may act in a
redundant fashion and led to the hypothesis that the receptors are
the rate-limiting factor.
There are four members of the ERBB family of receptor
tyrosine kinases: the epidermal growth factor receptor (Egfr/Erbb1)
and v-erb-b2 erythroblastic leukemia viral oncogene homolog 2–4
(Her2, Erbb3 and Erbb4, respectively). Whole animal knockouts of
ERBB receptors results in embryonic lethality, demonstrating the
critical role in physiology these receptors play [27–32]. Erbb1-3 are
expressed in the mouse endometrium while Erbb4 localizes pre-
dominantly to the muscular myometrium and has been shown to
not be critical for fertility [33–36]. In the present study, we
examined the role of Erbb1-3 in the endometrium using loss-of-
function approaches in mice and primary human endometrial
stromal cells and determined that that EGFR critically regulates
endometrial function.
Results
Egfr ablation results in severe subfertility
To circumvent the embryonic lethality exhibited by whole body
ERBB knockout animals, mice carrying floxed alleles [37–39]
were crossed with the PgrCre mouse model [40], effectively ablating
Erbb expression in the uterus (Figure 1). To determine the impact
that Erbb ablation has on female fertility, control (Pgr+/+Erbbf/f; f/f)
and knockout females (PgrCre/+Erbbf/f; d/d) were mated with wild
type males of proven fertility in a 6-month fertility trial. Uterine
ablation of Egfr (Erbb1) had a major impact on endometrial
function, causing infertility in three of seven females tested, while
four of the seven females produced only 10 pups over a six month
period. In contrast, ablation of either Her2 (Erbb2) or Erbb3
resulted in only a modest impairment in the average litter size
(Table 1). Given that of the Erbb receptors expressed in the
endometrium, ablation of Egfr had the most significant impact on
fertility, we chose to focus our investigation on this receptor.
No overt defects in ovarian or oviduct function using the
PgrCre to ablate Egfr expression
The PgrCre not only excises alleles in the uterus, but is also active
in the oviduct and during a brief window in the corpus luteum
[40]. Prior to investigating the loss of Egfr in the endometrium, the
role of Egfr in ovarian, luteal and oviductal function was inter-
rogated. To examine the ability to produce oocytes, 3-week old
females were stimulated with gonadotropins and mated with wild-
type males. At day 0.5 of pregnancy, ova were recovered from the
oviduct and no differences in the number present were observed
between genotypes (Figure S1A). To assay ovulation, fertilization
and blastocyst transport through the oviduct, naturally cycling
adult females were mated with wild-type males and blastocysts
were flushed from the uterus. Though a trend toward a lower
number of uterine blastocysts was observed in Egfrd/d females, the
difference was not statistically significant (Figure S1B). Important-
ly, following flushing of the uterus, the oviducts were dissected to
examine whether any blastocysts failed to be transported to the
uterus and none were observed. Luteal function was examined by
measuring the serum concentration of progesterone at day 5.5 of
pregnancy, and no differences were observed (Figure S1C). Together,
these data suggest that ovarian function is largely intact and the
subfertility observed in Egfrd/d females is due to uterine defects.
Egfr ablation does not inhibit the acute response to
hormones
We next sought to determine how the loss of Egfr impaired
female fertility. It is well known that the uterus is a steroid hor-
mone responsive organ, and the actions of estrogen (E2) and
progesterone (P4) are absolutely critical for the establishment of a
successful pregnancy (reviewed in [14]). Many previous reports
have identified a potential link between EGF and E2 action
[41,42]. To determine whether the impairment in fertility observed
in Egfrd/d females was due to deficient E2 action, ovariectomized
mice were given three daily injections of E2 and the E2-dependant
induction of uterine wet weight and target gene expression were
assessed. Surprisingly, there was no difference in uterine weight gain
or in E2 target gene expression between Egfrf/f and Egfrd/d females
(Figure 2A, B). Next, we sought to determine whether the observed
subfertility was due to defects in progesterone action. To address this
possibility, ovariectomized mice were treated with a single dose of
P4 for 6 h and target gene expression was measured by qPCR. As
expected, expression of acute P4 target genes Ihh, Il13ra2, Cyp26a1
and Areg was induced after ligand exposure (Figure 2C). The ability
of Egfrd/d uteri to induce expression of Ihh, Il13ra2, and Areg was
Author Summary
Approximately 10% of reproductive aged women are
considered infertile. While great strides have been made in
assisted reproductive technologies, overall success rates,
especially considering the cost, remain low. Studies
indicate that due to its sequential nature, nearly 75% of
pregnancy failures are due to defects that occur very early
in gestation. Therefore, understanding the physiological
changes that occur in the endometrium during this period
and how those changes are regulated is of paramount
importance if we are to improve our ability to address
female reproductive health concerns. We investigated a
family of growth factor receptors and identified one that
critically regulates the growth and survival of the endo-
metrium in response to the implanting embryo. Further-
more, we used unbiased approaches to identify which
signaling pathways and genetic networks are activated
downstream of this receptor to execute each of the
processes necessary for a successful pregnancy. Under-
standing the mechanisms and genetic networks with
which pregnancy is regulated is a prerequisite to the
development of effective pharmaceutical therapeutics.
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Figure 1. Egfr is effectively ablated in the murine uterus. Successful generation of an Egfr conditional knockout (Egfrd/d) using the PgrCre mouse
model as determined by (A) qPCR; average +/2 SEM. ***-p,0.001, (B) western blot and (C) immunofluorescence. Scale bars 50 mm.
doi:10.1371/journal.pgen.1004451.g001
Table 1. Egfr (Erbb1) is the predominate endometrial Erbb receptor of female fertility.
Genotype Females Pups Litters Pups per Litter Litters per Female
Erbb1f/f 7 342 42 8.24+/20.34 6.00+/20.31
Erbb1d/d 7 10 8 1.50+/20.50 1.14+/20.46
Erbb2f/f 5 186 23 8.12+/20.48 4.60+/20.51
Erbb2d/d 5 128 25 5.15+/20.48 5.00+/20.45
Erbb3f/f 4 181 23 7.91+/20.50 5.75+/20.25
Erbb3d/d 5 137 24 5.79+/20.40 4.80+/20.20
6 month breeding trial using wild-type males. Average numbers are +/2 the SEM.
doi:10.1371/journal.pgen.1004451.t001
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Figure 2. Ablation of Egfr does not impair acute hormone responsiveness. Mice were ovariectomized and treated with: (A,B) estrogen for
3 d or (C) progesterone for 6 h. (A) Measurement of the induction of uterine wet weight in response to estrogen. qPCR measurement of hormone
target genes after (B) 3 d of estrogen or (C) 6 h of progesterone. Average +/2 SEM. *-p,0.05; **-p,0.01; ***-p,0.001.
doi:10.1371/journal.pgen.1004451.g002
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comparable to that of controls. The expression of Cyp26a1 trended
toward being reduced, but this difference was not statistically
significant.
Egfrd/d females exhibit normal expression of
preimplantation markers
Pregnancy requires the coordinated orchestration of P4 and E2
action, and this first becomes evident in the preimplantation
period when the uterus undergoes a switch from predominantly
E2-mediated physiology to P4-mediated action. Two days prior to
blastocyst attachment, the uterine epithelium is proliferating under
the influence of E2. Following ovulation and the luteal production
of P4 one day prior to attachment, proliferation ceases in the
epithelium while it is induced in the stroma. Exogenous hormones
may be given to mice to mimic this period free of ovarian or
embryonic influences [43]. With this regimen, Egfrf/f mice exhibit
the characteristic induction of epithelial proliferation with E2
(Figure 3B) as well as the inhibition of epithelial proliferation and
concomitant induction of stromal proliferation after P4 treatment
as measured by BrdU incorporation (Figure 3C). Under the same
Figure 3. Ablation of Egfr does not alter delayed pregnancy proliferation or preimplantation markers. Mice were ovariectomized and
treated with exogenous hormones to mimic various stages of preimplantation biology. (A–F) Measurement of proliferation by BrdU
immunohistochemistry in (A–C) Egfrf/f or (D–F) Egfrd/d mice primed with estrogen and then treated with (A,D) vehicle, (B,E) estrogen or (C,F)
estrogen (50 ng) and progesterone for 15 hours. Scale bars: 100 mm. (G,H) Mice were treated with 3 days of estrogen (100 ng), given 2 days rest and
then treated for 2 days with estrogen (6.7 ng) and progesterone (1 mg) to mimic day 3.5 of pregnancy. (G) Measurement of uterine wet weights after
oil or hormone treatment. (H) qPCR measurement of known preimplantation regulators.
doi:10.1371/journal.pgen.1004451.g003
EGFR Regulates Early Pregnancy
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hormone paradigm, the response of Egfrd/d mice did not differ
from controls (Figure 3E, F). To further investigate the preim-
plantation period, and because Egfr has been identified to be
involved in IHH signaling during the preimplantation window, we
also measured the expression level of several genes in this signaling
axis. No significant differences in the expression level of Ihh, Ptch,
Gli1 or COUP-TFII were found between Egfrf/f and Egfrd/d mice
(Figure 3H).
Early pregnancy failure and implantation site demise is a
key factor in female Egfrd/d subfertility
With no apparent defects during the preimplantation period, we
next chose to investigate a potential role for Egfr during blastocyst
implantation. To address this, control and conditional knockout
mice were mated with wild-type males. The morning a vaginal
plug was observed was considered day 0.5 of pregnancy, and mice
were sacrificed at various time points thereafter. Beginning at day
5.5, one day after blastocyst attachment, implantation sites and
decidual balls were readily observable in Egfrf/f females (Figure 4A).
Likewise, implantation sites were visible in Egfrd/d females (Figure 4D),
indicating that the uterus is at least permissive and capable of
blastocyst attachment and implantation. However, the average
number of observed implantation sites (Figure 4G) and the size of
those observed was reduced (Figure 4H). We next asked whether
the differences observed at day 5.5 were simply due to a delay in the
timing of pregnancy, as occurs in the previously mentioned Hb-
egf d/d model, or if the attenuated implantation reaction would have
a ripple effect and manifest as a more severe phenotype later in
pregnancy. At day 6.5 of pregnancy, obvious increases in implan-
tation site size can be observed in Egfrf/fmice (Figure 4B). However,
implantation sites in Egfrd/d mice fail to show a significant increase
in diameter (Figure 4E). Furthermore, intrauterine hemorrhaging
indicative of embryo resorption is readily apparent in Egfrd/d mice.
Continued observation of pregnancy progression to day 9.5 reveals
that while the Egfr f/f implantation sites develop normally (Figure 4C),
those in Egfrd/d females fail to recover from the early impairments in
implantation and continue to be reabsorbed (Figure 4F).
Implantation site demise is due to a failure in the
maintenance and progression of decidualization
The attachment of the blastocyst to the uterine epithelium and
subsequent invasion into the adjacent stroma triggers the prolifera-
tion and differentiation of said cells in a process termed deciduali-
zation (reviewed in [5]). To investigate the cause of implantation
failure, we assessed the ability of Egfrd/d mice to mount a decidual
response following exogenous hormone treatment and mechanical
Figure 4. Egfr ablation causes blastocyst implantation site demise. (A–F) Gross morphology of pregnant uteri. (A–C) Egfrf/f and (D–F) Egfrd/d
females were mated with wild-type males. The morning observance of a vaginal plug was considered day 0.5 of pregnancy. Pregnancy was assessed
at (A,D) d5.5, (B,E) d6.5 and (C,F) d9.5. Scale bars: 1 cm. (G) Average number of implantation sites observed. (H) Average lateral diameter of
implantation sites. Numbers represent average +/2 the SEM. **-p,0.01; ***-p,0.001.
doi:10.1371/journal.pgen.1004451.g004
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deciduogenic stimulus. One day after stimulation (analogous to
day 5.5 of natural pregnancy), the hallmark induction of biomass
and increased size of the stimulated horn is apparent in Egfrf/f mice
(Figure 5A). Similar to the findings during implantation, Egfrd/d
uteri do exhibit a response to deciduogenic stimuli, however, one
that is dampened. Also similar to implantation, while the control
uteri continue to increase in size two days after stimulation (analo-
gous to day 6.5 of natural pregnancy), Egfrd/d uterine horns fail to
Figure 5. Egfr ablation results in major defects in decidualization. Ovariectomized mice were treated with exogenous hormones and a
deciduogenic stimulus was administered to one uterine horn. Gross uterine morphology of uteri (A) 1 day, (B) 2 days, or (C) 5 days after deciduogenic
stimulus. Scale bar: 1 cm. (D) Wet weight ratio of stimulated uterine horn relative to unstimulated horn. Histological analysis of day 2 stimulated
uterine cross-sections comparing (E–G) Egfrf/f and (H–J) Egfrd/d. (E,H) Proliferative marker phospho-histone H3, (F,I) apoptosis via TUNEL assay, and
(G,J) differentiation via alkaline phosphatase staining. Scale bars: 100 mm (E,H,F,I) and 50 mm (G,J). (K) Measurement of the induction of mRNA
expression of known decidual regulators on day 1 uteri by quantitative real-time PCR. Average +/2 SEM. *-p,0.05; **-p,0.01; ***-p,0.001. n.s. - not
significant.
doi:10.1371/journal.pgen.1004451.g005
EGFR Regulates Early Pregnancy
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progress, and they regress to a point where stimulated horns are
indistinguishable from those that were left unstimulated (Figure 5B).
When the decidual response five days after stimulation (analogous to
day 9.5 of pregnancy) was assayed, the difference between Egfrf/f
and Egfrd/d mice is greater than 10-fold (Figure 5C,D), which is in
contrast to the lack of detectable differences between Erbb2 or Erbb3
mice and their respective controls during decidualization (Figure S2).
As mentioned previously, decidualization is a complex process
that begins with a wave of proliferation that eventually leads to
differentiation. To determine whether defects in any of these cellular
functions may be contributing to the decidualization phenotype, we
used immunohistochemistry to compare tissue cross-sections of
stimulated uterine horns. When day two stimulated sections were
stained using an antibody against the mitotic marker phospho-
histone H3, positive immunoreactivity was observed in the nuclei of
many Egfrf/f stromal cells (Figure 5E). Strikingly, cross-sections from
Egfrd/d uteri exhibit very few immunopositive cells (Figure 5H).
Because it appeared as if though Egfrd/d mice were able to initiate
decidualization but failed to maintain it, we next asked if the
observed decrease in proliferation was coupled with increased apo-
ptosis. While the uterine epithelium of sections from control mice
were positive for terminal deoxynucleotidyl transferase dUTP nick
end labeling (TUNEL), a process known to aid blastocyst invasion,
the subepithelial stroma was negative (Figure 5F). Conversely, no
staining was observed in the epithelium of Egfrd/d sections while
many of the subepithelial stromal cells did stain positively (Figure 5I).
Differentiation of decidualizing cells follows the wave of prolifera-
tion. To determine whether defects in proliferation prevented
advancement of decidualization to differentiation or if the cells that
were able to initiate a response were then able to successfully
differentiate, alkaline phosphatase staining was performed. Robust,
pervasive dark purple staining is detected in the stroma of deci-
dualizing control mice (Figure 5G), which is largely absent in the
knockout sections (Figure 5J).
Previous work has identified important molecular mediators and
markers of decidualization, including Bmp2 [44,45], Wnt4 [46],
and their effectors. The expression of these genes was measured in
both unstimulated and stimulated uterine horns of Egfrf/f and
Egfrd/d mice. As expected, the expression of Bmp2,Wnt4, Ptgs2, Id1,
Fkbp5 and Fst show robust induction in the stimulated uterine horn
of Egfrf/f mice. When examining the expression of these genes in
Egfrd/d mice, no significant differences were found between stimu-
lated and unstimulated horns (Figure 5K). Together, these results
demonstrate that pregnancy demise in the absence of Egfr is due to
multiple failures during decidualization.
Microarray analysis reveals that BMP2 and WNT4 are
major mediators of EGFR action
To gain further insight into the concatenation of these genes
and which cellular processes are affected in their respective absence,
microarray analysis was conducted comparing gene signatures
between each knockout and their respective controls (Egfrd/d vs Egfrf/f;
Wnt4d/d vsWnt4f/f) using day 1 decidual uteri. Additionally, published
microarray data comparing Bmp2d/d uteri to controls under identical
conditions was used for comparison [45]. Using uniform gene calling
(see methods), a total of 3,529 genes were altered in the absence of
Egfr, 1,414 genes in the absence of Bmp2 and 1,305 genes in the
absence of Wnt4 (Table 2). More significantly, when the gene
signatures of each respective model were compared, significant
overlap was observed, with 80.7% and 65.8% of genes regulated by
Bmp2 and Wnt4, respectively, also being regulated by Egfr. How-
ever, a large number of genes (54.5%) regulated by Egfr are unique
and not altered in the absence of either Bmp2 or Wnt4 (Figure 6A).
Together, these data implicate a hierarchy in which EGFR signaling
acts genetically upstream, while BMP2 and WNT4 act as down-
stream mediators.
We next used the Database for Annotation, Visualization and
Integrated Discovery (DAVID) to determine which gene ontologies
and cellular functions were most affected in each model [47,48].
Analysis on the EGFR gene signature revealed a strong enrichment
in cell division, chromatin modification and kinase signaling.
Validation of the microarray results was achieved by qPCR of
representative genes using independent samples (Figure 6B). Of the
1,305 genes significantly altered in the absence ofWnt4, there was a
strong enrichment in developmental processes, chondrogenesis and
tube development. Genes that were upregulated (Figure 6C) as well
as those with reduced induction (Figure 6D) were validated by
qPCR. Interestingly, when the genes in common between the
EGFR and WNT4 signatures were analyzed, enrichments in
morphogenesis, cell junctions, urogenital development and ion
channels were found. Although analysis on the Bmp2 array has been
previously published [45], the fact that Bmp2 was one of the most
misregulated genes in the absence of Egfr and the gene signatures
have extensive overlap led us to investigate which processes were
regulated by both genes. Enrichments in chromatin remodeling,
metabolism, nucleic acid processing and molecular localization
were found, and candidate genes from these processes were
validated by qPCR using samples from Bmp2d/d uteri (Figure 6E,
F). When functional analysis was conducted on the 394 genes that
were altered in all three microarrays, enrichments for adhesion and
matrix interaction, cell cycle, DNA replication and metabolism
were found. Importantly, while Bmp2 and Wnt4 were misregulated
in the absence of Egfr (and each in its reciprocal array), Egfr is not
altered in their absence (Summarized in Figure 6G).
EGFR regulates human endometrial stromal cell
decidualization
Primary human endometrial stromal cells (HESC) can be
isolated, cultured in vitro and treated with a hormone cocktail of
estrogen, progestin and cAMP (EPC) to induce decidualization
[49]. To test whether EGFR is important for human decidualiza-
tion, we combined this system with a siRNA loss of function
approach. HESC transfected with a non-targeting pool of control
siRNA and treated with EPC show robust induction of classic
decidual markers IGFBP1 and PRL. Conversely, in cells transfect-
ed with EGFR siRNA, the induction of these markers is markedly
impaired (Figure 7A). In addition to changes in gene expression, it
is known that stromal fibroblasts undergo a transformation to an
epithelioid, cobblestone morphology (reviewed in [50]). While a
single representative image can sometimes effectively illustrate the
difference between two groups of cells, they are often subjective.
To address this, changes in cell morphology were quantified using
a high-content, automated imaging system. Cells were transfected
with siRNA, treated with EPC and then fixed at various times.
Table 2. Summary of microarray gene expression changes.
Genotype Up Down Total
Egfr 1980 1549 3529
Bmp2 664 750 1414
Wnt4 775 530 1305
RNA was isolated from decidual day 1 uteri of PRcre conditional knockouts and
their respective Cre-negative controls. Probes with a fold change $+/2 1.4 and
a p-value,0.01 were considered significant.
doi:10.1371/journal.pgen.1004451.t002
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Figure 6. Decidual microarrays reveal BMP2 and WNT as EGFR mediators. (A) Venn diagram comparing gene expression signatures from
Egfr, Bmp2 and Wnt4 conditional knockout day 1 decidual uteri. (B–F) Quantitative real-time PCR validation of microarray results using independent
samples, normalized to control expression. (B) Validation of genes altered in the absence of Egfr. (C) Validation of genes with reduced expression and
(D) elevated expression inWnt4 uteri. (E) Validation of genes with reduced expression and (F) elevated expression in the absence of Bmp2. (G) Model
depicting which cellular processes and gene ontologies are deregulated in the respective mouse models as determined by DAVID analysis.
doi:10.1371/journal.pgen.1004451.g006
EGFR Regulates Early Pregnancy
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Whole cells and nuclear fractions were imaged using CellMask
Blue and DAPI, respectively, while antibodies recognizing IGFBP1
and EGFR were used for immunofluorescence. In cells transfected
with non-targeting siRNA, large nuclei (Figure 7B), a rounded,
cobblestone cell morphology (Figure 7C) and high levels of IGFBP1
(Figure 7D) and EGFR (Figure 7E) are observed. Strikingly, when
EGFR expression is significantly attenuated (Figure 7I, L), cells
maintain a spindle-like, fibroblast morphology (Figure 7G) and
Figure 7. EGFR attenuation inhibits human endometrial stromal cell (HESC) decidualization. HESC were transfected with non-targeting or
EGFR siRNA. After 48 h, HESC were treated with deciduogenic hormones and assessed at day 0, day 3 and day 6. (A) qPCR analysis of known decidual
markers and regulators. (B–L) Day 6 automated quantitative image-based analysis of the effects of siEGFR on decidualization. (B–I)
Immunofluorescent images of HESC transfected with (B–E) non-targeting siRNA or (F–I) EGFR siRNA after 6 days of deciduogenic hormones.
(B,F) DAPI staining of nuclei (470 nm, low exposure). (C,G) Staining of cell surfaces with CellMask Blue stain (470 nm, high exposure). (D,H)
Immunolableing of decidual marker IGFBP1. (E,I) EGFR immunolabeling. (J–L) Quantification of siEGFR and decidual changes. (J) Measurement of cell
size. (K) Induction of IGFBP1 expression. (L) Day 6 expression levels of EGFR. Average +/2 SEM. *-p,0.05; **-p,0.01; ***-p,0.001.
doi:10.1371/journal.pgen.1004451.g007
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exhibit only basal levels of IGFBP1 expression (Figure 7H).
Following segmentation and quantification (see methods), signifi-
cant increases in cell size (Figure 7J) and IGFBP1 expression
(Figure 7K) can be quantified over time, while no significant
differences were observed between treated and untreated HESCs
lacking EGFR.
Direct and decidual-dependent kinome alterations
following EGFR attenuation in HESC
The receptor tyrosine kinase EGFR is capable of activating a
plethora of signaling cascades, and thus it is likely that the mech-
anisms by which the aforementioned impairments in decidualiza-
tion and pregnancy are affected involve phosphorylation. To
investigate which phosphorylation events may be altered in the
absence of EGFR, we utilized phospho-kinase antibody arrays.
HESC were treated with either HB-EGF for 30 minutes (Figure 8A)
or EPC for 3 days (Figure 8B) to examine the role of EGFR
signaling both acutely and throughout decidualization. Widespread
alterations in many phosphorylation events were evident in cells
with attenuated EGFR expression. Of the 44 different substrates in
the array (Table S1), 11 were altered (absolute fold .1.5) only
following HB-EGF treatment, 12 were altered only following EPC
treatment, and 11 were altered after both HB-EGF and EPC
treatment (Figure 8A–C).
To corroborate the results of the kinase arrays as well investigate
whether the absence of EGFR was affecting the expression or
phosphorylation of the identified kinases, western blots with inde-
pendent samples were performed (Figure 8D). Utilizing this
approach, we were able to not only confirm that there are
widespread alterations in the total amount of phosphorylated
kinases present in cellular extracts, but we also identified changes
in the expression of several proteins that was dependent on either
treatment type or EGFR status. For example, intuitively, the
observed decrease in pEGFR is predominantly due to the siRNA-
induced depletion of total protein, but it was also observed that in
comparison to HB-EGF treatment, EGFR expression is induced
2.5-fold during decidualization. Another example is cJUN, which
is also induced during decidualization. Although phosphorylation
of cJUN is not detected in samples treated with HB-EGF, total
protein expression is virtually lost in the absence of EGFR. During
decidualization, total cJUN is reduced by approximately 50% and
the protein that remains is phosphorylated at approximately 50%
the rate observed in cells with EGFR expression, culminating in an
ultimate 75% reduction in phosphorylated cJUN (Figure 8D).
Importantly, b-catenin, a downstream effector of WNT signaling,
follows a similar pattern; it is induced during decidualization,
though to a lesser extent with hypophosphorylation in the absence
of EGFR. Additionally, we investigated the function of two
members identified in the array that have not yet been reported in
the endometrium, WNK1 and AKT1S1 (PRAS40), due to their role
as signaling intermediaries. Interestingly, the reduction in expres-
sion of either member by siRNA resulted in a significant atten-
uation in the expression of decidual markers IGFBP1 and PRL
(Figure 8E). These results identify and provide valuable insight
into the complex signaling networks important to endometrial
function.
Discussion
Erbb signaling, predominantly via EGFR, plays a vital role
in early pregnancy
In this report, we hypothesized that the receptors may be the
rate limiting factor of Erbb signaling in the regulation of female
fertility. We show that EGFR, the only Erbb receptor expressed in
the endometrium possessing both functional ligand binding and
active kinase activity, plays a critical role in fertility. Modest
reductions in litter size observed in the absence of uterine Her2 or
Erbb3 indicates that they may facilitate EGFR signaling as
dimerizing partners but do not play a critical role in pregnancy
individually. Growth factors bear their namesake due to the ability
to promote growth, and evidence of a relationship between they
and the mitogenic hormone estrogen has been well documented
[27,51,52]. Given the demonstrated relationship between EGF
signaling and estrogen, one might intuitively predict that the
fertility defects observed in Egfrd/d mice are due to impairments in
estrogen action. Surprisingly, neither epithelial proliferation nor
estrogen target gene expression was affected. Taken together, these
results suggest that although one of the functions of EGFR may be
the activation of the estrogen receptor, estrogen action itself does
not require the EGF-receptor.
We did, however, observe significant defects in blastocyst
implantation. The observation of implantation sites in the Egfrd/d
uterus one day after implantation indicates that the Egfr is not
necessary for the recognition of and initial response to the
blastocyst, and its absence is still permissive of attachment and
invasion. Although a reaction is initiated, it is one that is dimin-
utive and abbreviated, and this may explain the reduction in the
number of macroscopically observable implantation sites. We
observed EGFR expression in the stromal compartment during
this period, and the predominant ligand, HB-EGF, is first
expressed in the luminal epithelium at the time of attachment
but can then be subsequently observed in proliferating stromal
cells [22]. Thus it is intuitive that the primary uterine phenotypes
would be in stromal cell function at the site of blastocyst invasion.
Defects during the periimplantation period are especially clinically
relevant as 30% of human pregnancies are lost during the
immediate weeks following attachment [7]. Pregnancy demise due
to defects during implantation is a phenomenon that is recapit-
ulated herein when the small implantation sites in Egfrd/d uteri fail
to progress and intrauterine hemorrhaging and fetal resorption ensue.
Egfr plays a pivotal role in the amplification of
decidualization
The decidua plays a critical role in regulating trophoblast
invasion, modulating the local immune response, protection from
reactive oxygen species and development of the placenta. Con-
sequently, defects in decidualization ripple throughout pregnancy,
manifesting in adverse obstetric outcomes such as those in pla-
cental position (placenta accreta, placenta previa) and sufficiency
(preeclampsia and intrauterine growth restriction), miscarriage,
recurrent pregnancy loss, and infertility (reviewed in [6]). Exam-
ining the cause of implantation site demise in Egfrd/d uteri, we
observed that EGFR plays a critical role in the amplification and
maintenance of decidualization. In results complementing natural
pregnancy, an initial response to deciduogenic stimuli did occur,
albeit to a lesser extent. However, as the decidua continued to
expand in control mice two days after stimulation, proliferation
was nearly absent in the stimulated horns of knockout uteri, which
had actually begun to regress due to increased apoptosis.
To investigate the global impact on gene expression caused by
the loss of Egfr, we conducted microarrays one day after deci-
duogenic stimuli and identified over 3,000 misregulated genes in
the absence of Egfr. Bioinformatics analysis revealed widespread
alterations including genes involved in: growth factor and kinase
signaling (Pdgfc, Fgf7, Fgrfr1, Igf1, Akt1, Akt2), the cell cycle (E2f3,
E2f8, Cdk4, Cdk6, Ccnd3), DNA replication (Mcm2, Mcm7) and cell
survival (Bcl2l1, Bax, Bak1, Birc5, Birc6). The gene networks iden-
tified here are in accordance with the phenotype observed where
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Figure 8. Direct and decidual-dependent kinome alterations following EGFR attenuation in HESC by kinase antibody array. (A–C)
HESC were transfected with non-targeting or EGFR siRNA and treated with (A) HB-EGF for 30 mins or (B) deciduogenic hormones for 72 h to
determine the effect on 44 different kinase substrates via kinase antibody arrays. (C) Relative (siEGFR vs non-targeting siRNA) quantification of
antibodies exhibiting an absolute fold change .1.5. (T) indicates an antibody recognizing total proteins; all others are phosphorylation specific. (D)
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deficient growth signals prevent the advancement of the cell cycle
and DNA replication, resulting in a concomitant loss in cell
survival. Additionally, we observed significant alterations to two
factors previously reported to play a key role in decidualization,
Bmp2 and Wnt4.
Of the many BMP ligands and receptors, Bmp2, Bmpr2 and
Acvr1 have been previously shown to play important roles in
endometrial function, with both early implantation (Bmp2 and
Acvr1) and mid-gestational (Bmpr2) defects, some reminiscent of
human intrauterine growth restriction [45,53,54]. Of the many
members of the WNT signaling family expressed during implan-
tation [55], several (Wnt4, Wnt6, Sfrp4, Dact1) were found to be
misregulated in the absence of Bmp2 [45]. Wnt4 is the gene that is
most abundantly expressed in the decidua, and its ablation
resulted in subfertility due to decreased stromal cell survival and
differentiation. Interestingly, the induction of Bmp2 during deci-
dualization was markedly impaired in the absence ofWnt4, leading
the authors to propose that Bmp2 and Wnt4 function in a mutually
activating relationship [46]. Together, these results suggest that the
three genes may regulate decidualization in a complex network.
To elucidate this relationship, we conducted a microarray on
Wnt4d/d day 1 decidua and compared it to both our Egfr micro-
array and a published Bmp2 decidual array.
Gene ontology and functional clustering revealed strong enrich-
ments in developmental processes in the 1,305 genes that were
altered in the absence of Wnt4. These results were fitting since
WNT signaling plays a well-documented role in uterine develop-
ment and differentiation [46,56–59]. Interestingly, when we inves-
tigated the relationship between Egfr, Wnt4 and Bmp2 by comparing
all three microarrays, Egfr appeared to be the predominant
regulator, not only encompassing 80.7% of the Bmp2 gene signature
and 65.8% of the Wnt4 signature, but also affecting an additional
1,923 unique genes. Furthermore, while Bmp2 and Wnt4 were
altered in all three models, Egfr was not affected in the absence of
either Bmp2 orWnt4, further suggesting a hierarchy in which Bmp2
and Wnt4 are mediators of Egfr action.
We were also able to identify distinct differences between the
enriched functions within the Egfr-Bmp2 and Egfr-Wnt4 common
genes. The 747 genes regulated by Egfr and Bmp2 exhibit enrich-
ment in general cell functions (RNA trafficking [Nup155, Nup160],
RNA processing [Lsm2], transcription elongation [Tcerg1]), and
metabolism (cholesterol and lipids [Apoe, Hmgcr, Cyp39a1, Fasn,
Scarb1], glucose [Hk1, Hk2] and respiration [Aox1, Aox3])). The 465
genes regulated by Egfr andWnt4 display an enrichment in cell fate
and differentiation with processes such as morphogenesis and
urogenital development (Foxa2, Zeb1, Sox9, Trp63), cell interaction
(Perp, Trp63) and cell survival/death (Dapk1, Dcc, Xaf1, Bnipl) being
enriched. By comparing three different mouse models, this analysis
provides valuable insight into how multiple signaling networks
converge in the execution of decidualization and thereby the
achievement of a successful pregnancy.
Attenuation of EGFR causes extensive alterations to
kinase signaling, preventing HESC decidualization
Treatment of cultured HESCs with a hormone cocktail of
estrogen, progestin and cyclic AMP (EPC) induces in vitro deci-
dualization, the hallmarks of which are the induction of IGFBP1,
PRL and transformation from a spindle-like fibroblast to an epi-
thelioid, cobblestone-like morphology [60]. Using molecular and
novel image-based approaches, we demonstrated that EGFR is
critical for human decidualization. Interestingly, while basal and
early decidual expression of PGR was unaffected by siEGFR, the
amplification of PGR mRNA late during decidualization was
blunted. The decidual induction of PGR makes it challenging to
determine whether EGFR signaling regulates PGR directly or if its
attenuation is due to the lack of decidualization. It has been
reported that predominant EGFR ligands during pregnancy, Hbegf
and Areg, as well as Egfr itself, are PGR target genes [21,25,61]. An
attractive conjecture would be that a feed-forward amplification
loop exists in which PGR induces EGFR signaling that in turn
feeds back to maintain PGR activation. Such a model would serve
as an exquisite sensor of progesterone activity, linking the health of
the pregnancy to endometrial function.
Enzymes, particularly kinases, are some of the most commonly
targeted proteins for therapeutic manipulation (reviewed in [62]).
To better understand which signaling pathways EGFR might be
acting through in HESC, we examined the activation of acute
targets 30 minutes after growth factor treatment as well as those
that are regulated during decidualization after 3 days of hormones.
Using phosphokinase antibody arrays and western blot confirma-
tion, we identified a wide array of kinome alterations in the absence
of EGFR.
Significant impairments in the rapid activation of members of
the SRC cascade (SRC, FAK, FYN, HCK, LCK, LYN, YES),
known to be important during HESC decidualization [63], were
evident in the absence of EGFR. Additionally, AKT/mTOR
signaling (AKT, WNK1, PRAS40, MTOR, P70S6K) as well as
MAPK and downstream effectors (P38a, RSK1/2/3, HSP27,
JUN, CREB) were inhibited following HB-EGF treatment. While
some of these same signaling members (AKT, GSK3b, ERK1/2,
P38a, PDGFR, FAK, LYN, YES) were also affected following
decidualization, pathways showing more dramatic alteration in
the hormone milieu include STAT signaling (STAT2, STAT3,
STAT5a/b, STAT6), the response to cellular stress (AMPKa1,
AMPKa2, HSP27, MSK1/2), and importantly CTNNB, a down-
stream WNT effector. The interconnected nature and cross talk
that exists between most signaling pathways makes the establish-
ment of definitive causal relationships difficult, but it is clear that
the absence of EGFR causes widespread havoc on intracellular
signaling and thus prevents the feed-forward amplification of
decidualization.
Additionally, we demonstrate that inhibition of EGFR signaling
intermediaries AKT1S1 or WNK1 also impairs HESC decidualiza-
tion. The identification of a role for WNK1 in decidualization is
particularly intriguing. WNK1 is a member of the WNK subfamily
of kinases that is most prominently known to play important roles
in the regulation of ion transporters and electrolyte homeostasis.
Mutations in WNK1 were discovered to cause a familial form of
hypertension known as Gordon’s syndrome, characterized by
increased renal salt reabsorption [64]. Additionally, WNK1 has
been shown to regulate the epithelial sodium channel ENaC [65],
an interesting finding considering endometrial ENaC has recently
been shown to be critical for blastocyst implantation and is
markedly reduced in women who experience an unsuccessful in
vitro fertilization cycle [66]. Although we are the first to show that
WNK1 is activated downstream of EGFR signaling in endometrial
cells, additional evidence of this relationship exists in that WNK1
was shown to be required for the EGF-dependent activation of
Validation of kinase array results by western blot using independent samples. (E) HESC were transfected with non-targeting (NT), WNK1, or AKT1S1
siRNA, treated with deciduogenic hormones for 6 d and the expression of decidual markers was measured by qPCR. Numbers represent average +/2
the SEM. **-p,0.01; ***-p,0.001.
doi:10.1371/journal.pgen.1004451.g008
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ERK5 in kidney cells [67]. While the WNK family is most similar
to the MEKK family of kinases, they are atypical in that they do
not fit in any of the seven major kinase families [68]. Of the 518
different protein kinases identified in the human genome, 428 of
them utilize a highly conserved lysine in subdomain II [69]. In
contrast, the WNK family bears their namesake (With No Lysine
[K]) due to the absence of this important residue [68,70]. The
atypical catalytic domain of WNK proteins not only confers
unique substrate binding but also represents an attractive target for
the development of specific small molecules. For example, while
the acute nature of targeted periimplantation growth factor
supplementation in women with a history of pregnancy compli-
cations would likely limit the potential for adverse side effects,
EGFR is expressed in many tissues and is well known to play
oncogenic roles in the brain, lung, breast, pancreas and colon.
Development of pharmaceuticals targeting the atypical kinase
domain of WNK1 could potentially confer not only target protein
specificity but also reduce non-uterine effects.
Summary
Our present findings demonstrate that the coordinate actions of
EGFR are critical for the successful progression of early preg-
nancy. The serial, progressive nature of pregnancy prescribes that
deficiencies in early events generate ripple effects, potentially
leading to pregnancy termination [6]. Thus, identification and
modulation of members involved during this period is of para-
mount importance in the improvement of female reproductive
health. We show here that EGFR is active during this window,
triggering a multitude of signaling and transcriptional events, and
thus it establishes the cellular context necessary for the continued
progression of pregnancy. Several studies have implicated a poten-
tial a role of EGFR signaling in human pregnancy. A maternal
polymorphism in the 59 untranslated region of the EGF locus was
associated with intrauterine growth restriction (IUGR) [71].
Similarly, decreased expression and activation of EGFR is asso-
ciated with low birth weight and IUGR [72–74]. Elucidation of
the EGFR signaling network also has implications beyond
reproductive health as it is overexpressed in approximately 50%
of endometrial tumors and is significantly associated with
decreased survival in patients with Type II endometrial cancer
[75,76]. Furthermore, expression of negative regulators of EGFR
signaling, TOB1 and MIG6, has been found to be reduced in
women with endometriosis [77,78]. Insight gained herein will aid
in the development and advancement in our ability to treat women
suffering from reproductive dysfunction.
Methods
Mice and human specimens
Floxed Erbb mice were crossed with the progesterone receptor
cre mouse model to generate conditional knockout models. All
mice were maintained under pathogen-free conditions. Animal
handling and surgery was performed according to the NIH Guide
for the Care and Use of Laboratory Animals. All procedures and pro-
tocols were approved by the Institutional Animal Care and Use
Committee at Baylor College of Medicine. Typical cohorts
consisted of 5–10 mice unless specified otherwise.
Endometrial samples were obtained from the proliferative phase
of normally cycling women after written informed consent, under
an approved protocol by the Institutional Review Board of Baylor
College of Medicine. Histologically normal endometrial tissue
samples were obtained by biopsy from subjects between 18 and 45
years of age who had no history of uterine disease. Samples were
collected at the room temperature and transported to the laboratory
in HBSS containing 1% antibiotic-antimycotic (Life Technologies,
Carlsbad, CA, USA) on ice and processed for the endometrial
stromal cell isolation as described below.
Fertility study and murine hormone treatments
Conditional knockout and respective control females were
paired with wild-type males of proven fertility (1:1) at approxi-
mately 8 weeks of age. Fertility was assessed by monitoring litter
size and frequency over a six month period. Stimulation of ovula-
tion was induced in 3-week old female mice (N= 3 f/f, 5 d/d) by
administering 5 IU of pregnant mare’s serum gonadotropin
intraperitoneally (i.p.; VWR Scientific), followed by 5 IU human
chorionic gonadotropin (i.p.; Pregnyl, Organon International)
48 hours later. Females were placed with wild-type males and
24 hours later ova were flushed from the oviducts and counted.
Natural ovulation, fertilization, and oviduct transport were mea-
sured in naturally cycling adult females mated to wild-type males.
At day 3.5 of pregnancy, uteri were excised and flushed and the
blastocysts recovered were counted. Serum progesterone at day
5.5 of pregnancy was measured following isolation by centrifuga-
tion using blood collected at the time of sacrifice and serum
separator tubes (BD). The serum was sent to the University of
Virginia Center for Research in Reproduction Ligand Assay and
Analysis Core for analysis of P4 by radioimmunoassay. Blastocyst
implantation was measured by mating 8 week old females with
wild-type males. The morning a vaginal plug was observed was
considered 0.5 days post coitus (day 0.5 of pregnancy). Mice were
sacrificed at day 5.5 (N= 6 f/f, 5 d/d), 6.5 (N= 7 f/f, 4 d/d) or 9.5
(N= 4 f/f, 5 d/d) of pregnancy. Uteri were excised, imaged and
implantation site diameter was measured using a vernier caliper.
For all experiments involving exogenous hormones, females were
ovariectomized between 6–8 weeks of age and given 10–14 days to
recover and purge endogenous hormones. Hormones were dissolved
in sesame oil and administered via 0.1 ml subcutaneous injection.
The effects of short term hormone were measured by either three
daily injections of 100 ng estradiol (E2) or a single 1 mg progesterone
(P4) injection. Mice were sacrificed 6 h after the final injection; uteri
were weighed and flash frozen. For preimplantation gene expression
studies, mice (N=6 f/f, 4 d/d) were given 3 d of 100 ng E2 followed
with 2 d of rest and then a combination of 6.7 ng E2 with 1 mg P4
for 2 days. Mice were sacrificed 6 h after the final injection, uteri
were weighed and flash frozen. For the investigation of preimplan-
tation proliferation using the delayed pregnancy model [43], all
mice were given 2 days of 100 ng E2 followed by 2 days of rest. At
this point, mice were divided into three cohorts (N=4 per genotype
per treatment): vehicle (4 days vehicle [oil] injections), E2 (3 days of
vehicle, 1 injection of 50 ng E2) or EP (3 days of 1 mg P4, 1
injection of 50 ng E2 and 1 mg P4). BrdU (GE Healthcare) was
injected intraperitoneally 13 hours after the final hormone injection
and mice were sacrificed 2 hours later. The artificial induction of
decidualization was achieved using previously described methods
[79]. Briefly, following 3 days of 100 ng E2, 2 days of rest and 3 days
of 6.7 ng E2 and 1 mg P4, mice were given a deciduogenic stimulus
of either 50 ul intrauterine sesame oil injection or mechanically via
a scratch with a burred needle. Mice were then given daily injections
of the combined E2 and P4 until the day of sacrifice (1 day, 2 days or
5 days after stimulus), 6 hours after the final injection. Uteri were
imaged, each horn weighed and then flash frozen.
Histological and immunohistochemical staining
At the time of sacrifice, a mid-portion of uterus was fixed in 4%
(v/v) PFA overnight followed by thorough washing with 70%
ethanol. Tissues were dehydrated in a graded ethanol series and
embedded in paraffin. Sections were cut (5 mm) and mounted on
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silane-coated slides. Tissues were deparaffinized, rehydrated and
boiled in citrate buffer for antigen retrieval. Sections were pre-
incubated in 10% normal goat serum (NGS) in PBS (pH 7.5) for
1–3 hours at room temperature. Tissue sections were incubated
overnight at 4uC with primary antibodies specific to phospho-
histone H3 (Millipore, 1:2000). After washing with PBS, sections
were incubated with biotin-labeled secondary antibody (Vector,
5 ml/ml) for 1 hour. Sections treated for immunohistochemistry
were then incubated with VECTASTAIN ABC solution (Vector
Labs) for 30 minutes followed by peroxidase substrate (Vector
Labs) for signal development. Immunoreactivity was detected
using the DAB substrate kit (Vector) and sections were counter-
stained with hematoxylin. The TUNEL assay was performed using
the Roche in situ cell death detection kit (Roche Applied Science)
according to manufacturer’s instructions. Alkaline phosphatase
staining was performed as previously described [46]. Briefly, 16 mm
sections were incubated with a 100 mM Tris buffer (pH 9.5)
containing 5-bromo-4-chloro-3-indolyl phosphate and nitro blue
tetrazolium chloride (Roche Applied Science). Nuclear Fast Red
(Vector) was used for counterstaining.
Western blot analysis
Protein was extracted using lysis buffer (50 mM Tris pH 7.4,
50 mM KCl, 6 mM EDTA, 1% NP-40) with PhosSTOP phos-
phatase and Complete protease inhibitors (Roche). Protein was
separated by electrophoresis using NuPAGE 4–12% Bis-Tris Gels
in MOPS buffer (Life Technologies). Proteins were transferred to
a PVDF membrane (Millipore) in transfer buffer (25 mM Tris,
192 mM glycine, and 20% methanol; Biorad). Membranes were
blocked in 5% nonfat dry milk which was dissolved in tris-buffered
saline/tween solution (TBS/T; 20 mM Tris, 150 mM NaCl,
pH 7.6, and 0.1% tween-20) and then incubated with primary
antibodies overnight at 4uC with gentle rocking. The membranes
were incubated with secondary antibody for 1 hour, washed with
TBS/T and developed with ECL prime reagents (GE Healthcare).
Quantitative real-time PCR
Total RNA was extracted using Trizol reagent (Life Technol-
ogies), according to the manufacturer’s directions. One microgram
of the RNA was reverse transcribed into cDNA with M-MLV (Life
Technologies). Expression levels of mRNA were measured by
TaqMan Universal PCR Master Mix (Applied Biosystems) or
FastStart Universal SYBR Green Master mix (Roche) using the
ABI 7500 and QuantStudio 12K Flex Real-Time PCR Systems,
according to the manufacturer’s instructions. Commercially vali-
dated Taqman real-time probes and primers were purchased from
Applied Biosystems. The sequences of primers used in SYBR qPCR
are listed in Table S2. Relative mRNA levels of transcript were
calculated by the 22DDC method, normalized to the endogenous
reference (18S), and plotted as mean 6 SEM.
Microarray analysis
Total RNA was isolated using RNeasy kits (Qiagen) from day 1
decidual uteri (see above) according to manufacturer’s instructions
and three groups of two were pooled for each condition. The
integrity of all RNA samples were tested with the Bioanalyzer
2100 (Agilent Technologies). Microarrays were performed by the
Genomic and RNA Profiling Core of Baylor College of Medicine.
Samples were labeled using the standard Affymetrix linear
amplification protocol using the 39 IVT Express Kit. 250 ng of
total RNA was reverse transcribed to produce double-stranded
cDNA. The cDNA product was used as a template for the vitro
transcription reaction, producing biotin-labeled cRNA. The labeled
cRNA was tested for integrity on the Agilent Bioanalyzer and
quantified using the NanoDrop ND-1000 spectrophotometer.
15.0 mg of the labeled cRNA was fragmented and re-checked for
concentration and size. Hybridization cocktails containing Affyme-
trix spike-in controls and 15.0 ug of each fragmented, labeled
cRNA were loaded onto Affymetrix GeneChip Mouse 430 2.0
arrays. The arrays were hybridized for 16 hours at 45uC with
rotation at 60 rpm in the Affymetrix GeneChip Hybridization
Oven 640. The arrays were washed and stained with a streptavidin,
R-phycoerythrin conjugate stain using the Affymetrix GeneChip
Fluidics Station 450. Signal amplification was done using bio-
tinylated anti-streptavidin. The stained arrays were scanned on the
Affymetrix GeneChip Scanner 3000. The images were analyzed
and quality control metrics recorded using Affymetrix Command
Console software version 3.0.0. Microarray CEL files were analyzed
using dChip (www.dchip.org, PM-MM model, Quantile normali-
zation). Two-side t-test and fold changes were used to define
differentially expressed probes. To obtain a non-redundant list of
significantly altered genes, multiple probe sets for a given gene
(when present) were averaged. Genes with an absolute fold change
$1.4 and a p-#0.01 were considered for further analysis.
Isolation, siRNA transfection, and hormone treatment of
human endometrial stromal cells
Endometrial stromal cells were isolated from tissue biopsies as
previously described [80] with slight modifications. In brief, tissue
samples were washed with DMEM-F12 (Life Technologies)
containing 1% antibiotic-antimycotic and minced into small
pieces of ,1 mm3. The tissues were then incubated for 1.5 hours
at 37uC in DMEM-F12 containing 0.25% (w/v) collagenase and
0.05% DNase I (Sigma-Aldrich). After enzymatic digestion, stromal
cells were separated from epithelial aggregates using a 40 mm nylon
cell strainer (BD-Biosciences). The filtrates were washed twice, and
plated in DMEM-F12 media containing 10% fetal bovine serum
and 1% antibiotic-antimycotic. Endometrial stromal cells were
passaged two to three times before the experiments. Endometrial
stromal cells were seeded in 6-well plates at a concentration of
1.56105 cells/ml, allowed to adhere and attain a confluency of
approximately 60%. Cells were then transfected with non-targeting
or Erbb siRNA (Thermo Scientific) using Lipofectamine 2000 or
RNAiMAX (Life Technologies) according to manufacturer’s
protocol. All decidual experiments were conducted in opti-MEM
media (Life Technologies) containing 2% charcoal-stripped fetal
bovine serum and 1% antibiotic-antimycotic. Stromal cultures were
treated with decidual hormones as described previously [49]. Deci-
dualization was induced by treatment with 1 mM MPA (Sigma-
Aldrich), 10 nM E2 (Sigma-Aldrich), and 50–100 mM dibutyryl
cAMP (Sigma-Aldrich) every 48 hours.
HESC immunofluorescence
HESC were grown on acid-etched glass coverslips (12-mm
diameter) before transfection and decidualization. Subsequent to
treatments, cells were washed once with PBS and fixed in 4%
paraformaldehyde (Electron Microscopy Sciences) for 30 minutes.
Excess fixative was quenched with freshly prepared sodium boro-
hydride (NaBH4; 1 mg/ml). After quenching, cells were washed
with TBS three times. Next, fixed cells were permeablized with
0.5% Triton X-100 for 30 minutes and washed with TBS three
times. Non-specific antibody binding was blocked by 5% milk/
TBS-T for 1 hour at room temperature. Primary antibodies
(IGFBP1, 1:200, Santa Cruz sc-6072; EGFR, 1:200, Cell
Signaling 2646) were diluted in blocking buffer and incubated
overnight at 4uC. The following day, cells were washed with TBS
and incubated with Alexa Fluor-conjugated secondary antibodies
(Life Technologies, 1:2000) in blocking buffer for 1 hour at room
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temperature. Then, cells were washed with TBS and post-fixed in
4% PFA for 10 minutes. Cells were washed and excess fixative
quenched again in NaBH4 for 10 minutes. Finally, cells were
treated with DAPI (1:1000) for 20 minutes and HCS CellMask
Blue (Life Technologies; 1:10,000) for 1 hour at room temperature.
Coverslips were rinsed quickly in water and mounted (SlowFade,
Life Technologies) onto slides. Coverslips were imaged immediately.
High throughput microscopy and image processing
Cells were imaged using the Cell Lab IC-100 Image Cytometer
(IC-100; Beckman Coulter) equipped with a 40X/0.90NA objec-
tive. The imaging camera (Hamamatsu Orca ER) was set to capture
8 bit images at 262 binning with at least 4 images captured per field
(DAPI, CellMask Blue, IGFBP1, EGFR). In general, .49 images
were captured per coverslip. Images were analyzed using custom
algorithms developed with the Pipeline Pilot (v8.0) software plat-
form (Accelrys) in a similar workflow as previously described [81–
83]. After background subtraction, nuclear and cell masks were
generated using a combination of non-linear least squares and
watershed-from-markers image manipulations of the DAPI images.
Cell populations were filtered to discard events with cell aggregates,
mitotic cells, apoptotic cells, cellular debris, or poor segmentation.
Applied gates were based upon nuclear area, nuclear circularity,
and cell size/nucleus ratio. All events with whole cell masks
bordering the edge of the image were additionally eliminated from
analysis. Post-analysis measurements were exported to spreadsheet
software (Microsoft Excel) for further analysis.
Assessment of kinase activity by Proteome Profiler
Human Phospho-Kinase array kits
HESC were transfected with siRNA as mentioned above. Cells
were split into two cohorts 24 hours after siRNA transfection. One
cohort was serum-starved for 24 hours and then treated with
decidual media (see above; containing 100 mM cAMP and 5%
charcoal-stripped FBS). Treatment media was changed after
35.5 hours and cells were harvested 30 minutes later. The other
cohort was double serum starved, starving for 12 hours overnight,
refeeding with 10% serum for 12 hours, and then serum-starved
again overnight. Cells were then treated with DMEM/F12 (Life
Technologies) containing 100 ng/ml rhHB-EGF (R&D systems)
for 30 minutes. Lysates were prepared using the supplied buffer.
Proteome Profiler Human Phospho-Kinase array kits (R&D
Systems) were used according to manufacturer’s instructions to
measure (in duplicate) changes to 43 different kinases and 2 related
total proteins. A total of 500 mg of protein was used for each cohort.
A total of 15 different x-ray exposures, ranging from 15 seconds to
15 minutes, were used to capture array signal. Signal intensity was
quantified using ImageJ (NIH) and was normalized to the reference
spots. Exposures with the greatest dynamic range for each pair of
antibody spots were used to determine the fold change in signal
intensity. Antibodies with an absolute intensity difference greater
than 1.5 were chosen for representation.
Statistical analysis
For comparisons involving two groups, unpaired two-tailed
student’s t-tests were performed. For comparisons involving three
or more groups, a one-way ANOVA followed by Tukey’s post hoc
multiple-range test was conducted.
Supporting Information
Figure S1 No overt defects in ovarian or oviduct function using
the PgrCre to ablate Eg fr expression. Conditional knockout mice (d/d)
and their respective controls ( f/f ) were mated with wild-type males
to investigate potential non-uterine defects. (A) 3-week old females
were stimulated with gonadotropins and embryos were recovered
from the oviduct at day 0.5 of pregnancy. (B) Blastocysts were
flushed from the uterine lumen at day 3.5 of pregnancy from
naturally cycling and mated females. (C) Serum progsterone con-
centration was measured at day 5.5 of pregnancy.
(TIF)
Figure S2 Normal decidualization in Erbb2 and Erbb3 condi-
tional knockout mice. Conditional knockout mice (d/d) and their
respective controls ( f/f ) were ovariectomized, administered exog-
enous hormones and one uterine horn was given a deciduogenic
stimulus. (A–D) Images of gross uterine morphology of (A) Erbb2f/f,
(C) Erbb2d/d, (B) Erbb3f/f and (D) Erbb3d/d mice 5 days after deci-
duogenic stimulus. Scale bars: 1 cm. (E,F) Wet weight measure-
ments of stimulated uterine horns relative to the unstimulated horn
of (E) Erbb2 and (F) Erbb3 females.
(TIF)
Table S1 A list of antigens recognized in the spotted human
phospho-kinase antibody array (R&D Systems).
(TIF)
Table S2 A list of oligonucleotide sequences used for SYBR
qPCR.
(TIF)
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